Stay informed with the latest Danaher media coverage.
2025
Dr. Sadik Kassim on Newsroom with Rosemary
CNN Newsroom
May 20, 2025
No roadmap and a ticking clock: Danaher’s Sadik Kassim joins CNN Newsroom to explore the urgent need for collaboration in advancing treatments for rare genetic disorders.
Watch here
Shifting the paradigm of biopharma innovation
The PharmLetter
May 19, 2025
Danaher’s Vanessa Almendro calls for a shift from traditional discovery to a platform-based design model in genomic medicine, highlighting how this approach, combined with regulatory and manufacturing innovation, could accelerate access to precision therapies. Subscription required.
Read more
ASGCT 2025: World’s First Patient Treated with Personalized CRISPR Therapy
GEN Edge: Genetic Engineering & Biotechnology News
May 15, 2025
A patient with a severe metabolic disease has improved after receiving an individualized gene editing therapy, offering the “tiniest bead of hope” for the family and a glimpse of a new era in genomic precision medicine.
Read more
A Baby Receives the First Customized CRISPR Treatment
Time
May 15, 2025
Researchers led by teams at Children’s Hospital of Philadelphia and University of Pennsylvania report on the first use of the gene-editing technology CRISPR in a customized therapy designed to treat one patient with a rare disease.
Read more
A Baby Received a Custom CRISPR Treatment in Record Time
Wired
May 15, 2025
Scientists were able to create a bespoke treatment for KJ Muldoon’s rare genetic disorder within six months. It could be a blueprint for potentially life-saving, gene-editing CRISPR therapies.
Read more
How the race to invent a drug for one sick baby made medical history
Washington Post
May 15, 2025
Scientists sprinted to create personalized medicine for baby KJ powered by CRISPR, a powerful gene-editing technology that won the Nobel Prize five years ago. Subscription required.
Read more
The real impact of AI on molecular design
Drug Discovery World
May 9, 2025
Martin Stumpe, PhD, Chief Data & Artificial Intelligence Officer at Danaher, examines the factors affecting AI’s impact on drug discovery.
Read more
Q&A: Shifting the Biopharma Paradigm from Discovery to Design
Pharmiweb
May 2, 2025
Danaher is collaborating with biopharmaceutical developers, manufacturers, and regulators to transform the drug development process into a more efficient and sustainable model; Vanessa Almendro highlights the importance of industry leaders and regulators working together to achieve this goal.
Read more
Q&A: A Bold Vision for ‘Hyperscaling Healthcare’
Pharmiweb
May 2, 2025
Artificial intelligence and other innovations in data science are fueling major advances in healthcare, from biopharmaceutical development to patient diagnostics, but the use of these tools is still somewhat limited; JC Gutierrez-Ramos explains his vision for expanding access to these technologies.
Read more
Danaher-IGI Beacon for CRISPR Cures Celebrates One-Year Anniversary
GEN Edge: Genetic Engineering & Biotechnology News
March 28, 2025
CRISPR leaders across the Innovative Genomics Institute (IGI) ecosystem came together to celebrate the one-year anniversary of the Danaher-IGI Beacon for CRISPR Cures collaboration.
Read more
AI: engineering for the human factor
nature
February 12, 2025
AI's transformative potential in healthcare demands addressing human responsibility, ethical frameworks, and cultural change for successful adoption.
Read more
Scrip Asks... What Does 2025 Hold For Biopharma? Part 4: Artificial Intelligence and Data Science
Citeline News and Insights
January 24, 2025
Martin Stumpe joins fellow industry leaders to share his expectations for the impact of AI on the biopharma industry over the coming year.
Read more
Behind the Headlines: 2025 Wish List
Pharmtech.com
January 15, 2025
Vanessa Almendro joins Behind the Headlines panel to discuss her ‘wish list’ for the progression of trends in the bio/pharmaceutical industry this year.
Read more
Behind the Headlines: 2024 Year in Review
Pharmtech.com
January 8, 2025
Vanessa Almendro joins Behind the Headlines panel to discuss 2024’s biggest trends in the pharmaceutical industry, as well as the unforeseen outcomes that took us by surprise.
Read more
From Promise to Practice: Danaher Gathers Visionaries to Discuss AI-Driven R&D
GEN Edge: Genetic Engineering & Biotechnology News
January 6, 2025
A line-up of experts across academia, pharma, and healthcare came together at the Danaher Summit in San Francisco to discuss the impact of AI on improving human health and implementation challenges to address in 2025 and beyond.
Read more